Mission
To provide leadership to advance the development, implementation and use of health preference research in support of health policy, the development of medical products, and patient care.
Goal
- To foster discussions about known and novel methods to obtain preference information and to analyze health-preference data in support of standards for the use of these methods
- To support early career researchers interested in the field of health preference research through involvement in the SIG activities
- To facilitate the dissemination of good practices for the methods used to collect and analyze health preferences in the HEOR community
- To identify and highlight ways in which preference evidence can support patient care and health policy and health economics and outcomes research
Background
Scientifically rigorous evidence on priorities and preferences is important in promoting patient-centered drug development, facilitating patient-centered outcomes research (PCOR), informing regulatory benefit-risk analysis, and conducting robust health technology assessment (HTA). Health preference research focuses on the development of instruments and other mechanisms to measure preferences for aspects of health policies, medical products, and patient care. These aspects are systematically evaluated by relevant stakeholders to determine their relative importance. The resulting measures of relative importance offer a unique way to understand the value of health-related initiatives and products. The broad array of methods and the ability to modify them allows their use for any number of research questions.
Manuscripts & Reports
- Vass C, Boeri M, Karim, et al. Accounting for preference heterogeneity in discrete-choice experiments: an ISPOR Special Interest Group Report. Value Health. 2022;25(5):685-694.
- Marsh, K, van Til, J. A, Molsen-David, E, et al. Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions—Report of the ISPOR Stated Preference Research Special Interest Group. Value in Health; 23(70):831-841
Presentations
Leadership
Chair-Elect
Christine Poulos, PhD, BA
Past Chair
Karin Groothuis-Oudshoorn, PhD
Chair
Kevin Marsh, PhD, BA, MA
Working Groups
Member Engagement
These activities allow for a variety of members to participate and also facilitates disseminating content in Webinars, Journal Clubs, Conference Sessions, etc.
Co-Chairs:
Siu Hing Lo
Riccarda Peters
Eline van Overbeeke, MSc
Janine van Til, PhD
Yuan Zhang
Key Project
Understanding Preference Heterogeneity: A survey of the state of practice
Co-Chairs:
- Marco Boeri, PhD, Senior Research Economist, RTI, Belfast, Northern Ireland, UK
- Sebastian Heidenreich, MSc, PhD, Patient Preferences - Associate Director, Evidera, Aberdeen, Scotland, UK
Questions or ideas? Please send an email.